FDA advisers on Sept. 27 voted against recommending an experimental treatment for Lou Gehrig’s disease.
Read the full post on Becker's Hospital Review - Healthcare News
FDA panel votes against controversial ALS drug candidate
FDA advisers on Sept. 27 voted against recommending an experimental treatment for Lou Gehrig’s disease.
Read the full post on Becker's Hospital Review - Healthcare News